Thomson Reuters (TRI) to Sell Healthcare Unit to Veritas for $1.25B
Tweet
Share
E-mailGet Alerts TRI Hot Sheet
Join SI Premium – FREE
Thomson Reuters (NYSE: TRI) announces definitive agreement to sell its Healthcare unit to Veritas for $1.25 billion.
The sale is subject to regulatory approval and customary closing conditions, including the expiration or termination of applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act, and is expected to close in the next few months. The sale is not subject to any financing condition. Veritas has obtained debt financing commitments for the transaction.
The sale is subject to regulatory approval and customary closing conditions, including the expiration or termination of applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act, and is expected to close in the next few months. The sale is not subject to any financing condition. Veritas has obtained debt financing commitments for the transaction.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robo.ai completes acquisitions, plans interim report for Aug. 24
- EigenQ files draft S-4 with SEC in SPAC merger with Silicon Valley Acquisition
- W. R. Berkley merges two units to form Berkley Meridian
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
